Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
Veillon
D M
DM
Nordberg
M L
ML
Glass
J
J
Sattar
T
T
Cotelingam
J D
JD
D015703:Antigens, CD / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D001853:Bone Marrow / Q000473:pathology; D002471:Cell Transformation, Neoplastic; D017338:Cladribine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000032:analysis; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D015448:Leukemia, B-Cell / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D015463:Leukemia, Prolymphocytic / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged
D015703:Antigens, CD; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D017338:Cladribine